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Supplementary Figure 1. (A) Assessing the purity of the PDK1 and AKT2 PH domains. The 
purity of the PH domains after S75 size exclusion chromatography was assessed by SDS-PAGE 
using a 4-12% polyacrylamide gel and visualised with the Gelcode protein staining solution. The 
fractions analysed correspond to peaks on the resulting chromatogram (A12-B3 and B1-B3 
indicate fraction number for the PH domain of PDK1 and AKT2 respectively). (B) Results from 
phosphokinase antibody array performed on lysates form MDA-MB-231 treated with 50 M 2-
O-Bn-InsP5 or vehicle alone and stimulated with EGF 50ng/ml for 3 minutes. (C) Representative 
Western blot of EGF-induced AKT serine 473 and ERK1/2 T202/Y204 phosphorylation in 
MDA-MB-231 untreated or treated with 50 M 2-O-Bn-InsP5.  
 
Supplementary Figure 2 
 
 
Supplementary Figure 2. Cell counting experiment assessing cell proliferation (10% serum) and 
survival (serum free condition) in MDA-MB-231 (A), MDA-MB-435 (B), TSA (C) and 4T1 cell 
lines (D) after 72 hours of treatment with 2-O-Bn-InsP5 and InsP5 (50 μM). Data are means ±SEM of 
values obtained from 3 independent experiments in duplicate. *p<0.05. 
 
